source
- FDA to end pilot aimed at preventing production issuesThe FDA said it will end a pilot that was intended to help drugmakers proactively address production issues. Few companies took advantage of the program during its three-year run. In April 2027, th…Endpoints · 6d ago↗ source
- Sartorius reduces revenue by €26M to refund Trump tariffs to customersSartorius appears to be the first life science company to detail how tariff refunds are affecting its revenue, following the US Supreme Court decision to block some of President Donald Trump’s levi…Endpoints · 6d ago↗ source
- Lilly, with new data, to seek FDA approval of obesity drug retatrutideThe new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions about the additive benefits a “triple-G” drug has on heart health.